Avalo Therapeutics (AVTX) Divestments (2019)
Avalo Therapeutics' (AVTX) quarterly Divestments came in at $4.0 million in Q4 2019.
Avalo Therapeutics (AVTX) Divestments (2019) Analysis & Trends
Avalo Therapeutics (AVTX) has 1 years of Divestments data on file, last reported at $4.0 million in Q4 2019.
- Quarterly Divestments changed N/A year-over-year to $4.0 million in Q4 2019, while the trailing twelve-month figure through Sep 2021 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $12.8 million, up 224.3% from the prior year.
- Divestments was little changed at $4.0 million in Q4 2019.
- In the past five years, Divestments ranged from a high of $4.0 million in Q4 2019 to a low of $4.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.96 Mn |